Cargando…
Synthesis of liver-targeting dual-ligand modified GCGA/5-FU nanoparticles and their characteristics in vitro and in vivo
Nanoparticle drug delivery systems using polymers hold promise for clinical applications. We synthesized dual-ligand modified chitosan (GCGA) nanoparticles using lactic acid, glycyrrhetinic acid, and chitosan to target the liver in our previous studies. We then synthesized the GCGA/5-FU nanoparticle...
Autores principales: | Cheng, Mingrong, Gao, Xiaoyan, Wang, Yong, Chen, Houxiang, He, Bing, Li, Yingchun, Han, Jiang, Zhang, Zhiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826867/ https://www.ncbi.nlm.nih.gov/pubmed/24232303 http://dx.doi.org/10.2147/IJN.S52877 |
Ejemplares similares
-
Synthesis of Glycyrrhetinic Acid-Modified Chitosan 5-Fluorouracil Nanoparticles and Its Inhibition of Liver Cancer Characteristics in Vitro and in Vivo
por: Cheng, Mingrong, et al.
Publicado: (2013) -
Optimized synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and their characteristics
por: Cheng, Mingrong, et al.
Publicado: (2014) -
Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells
por: Cheng, Mingrong, et al.
Publicado: (2013) -
PACAP/GCGa Is an Important Modulator of the Amphioxus CNS-Hatschek’s Pit Axis, the Homolog of the Vertebrate Hypothalamic-Pituitary Axis in the Basal Chordates
por: On, Jason S. W., et al.
Publicado: (2022) -
Inhibitory of active dual cancer targeting 5-Fluorouracil nanoparticles on liver cancer in vitro and in vivo
por: Cheng, Mingrong, et al.
Publicado: (2022)